Neurocrine Biosciences, Inc. $NBIX Shares Sold by Meiji Yasuda Life Insurance Co
Meiji Yasuda Life Insurance Co cut its stake in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 3.3% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 5,606 shares of the company’s stock after selling 194 shares during the […]
Meiji Yasuda Life Insurance Co Lowers Stock Holdings in Walmart Inc. $WMT
Meiji Yasuda Life Insurance Co reduced its position in Walmart Inc. (NYSE:WMT – Free Report) by 2.3% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 268,008 shares of the retailer’s stock after selling 6,218 shares during the period. Walmart comprises approximately […]
Meiji Yasuda Life Insurance Co Boosts Stock Position in The Goldman Sachs Group, Inc. $GS
Meiji Yasuda Life Insurance Co boosted its holdings in shares of The Goldman Sachs Group, Inc. (NYSE:GS – Free Report) by 1.4% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 25,336 shares of the investment management company’s stock after acquiring […]
Meiji Yasuda Life Insurance Co Trims Stock Position in Micron Technology, Inc. $MU
Meiji Yasuda Life Insurance Co trimmed its stake in shares of Micron Technology, Inc. (NASDAQ:MU – Free Report) by 30.5% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 92,837 shares of the semiconductor manufacturer’s stock after selling 40,726 shares […]
Meiji Yasuda Life Insurance Co Grows Position in Thermo Fisher Scientific Inc. $TMO
Meiji Yasuda Life Insurance Co increased its position in Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 0.4% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 14,718 shares of the medical research company’s stock after purchasing an additional 58 shares […]
last updated on 9 Sep 13:16